Condition
Lung Transplant Rejection clinical trials and research
As of November 12, 2026, Find a Trial lists 7 Lung Transplant Rejection clinical trials that are recruiting, at sites in 23 countries (most in United States (5), France (3), Austria (3)). By phase: Phase 3 (1), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 7Clinical trials
- 23Countries
Newest Lung Transplant Rejection clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Hyperpolarized xenon-129 MRI signatures to detect and manage acute cellular rejection after lung transplant | Phase 2 | Charlottesville, Virginia | Recruiting | Jul 2, 2025 |
| Comparing biopsy methods for lung transplant rejection diagnosis | — | Rochester, Minnesota | Recruiting | Feb 13, 2025 |
| Research on improving outcomes for lung transplant donors and recipients | — | Los Angeles, California and 18 other locations | Recruiting | May 3, 2024 |
| Evaluating extracorporeal photopheresis for subclinical lung transplant rejection | — | Vienna and 6 other locations | Recruiting | Nov 2, 2023 |
| Testing the effectiveness of belumosudil for treating lung transplant rejection | Phase 3 | Birmingham, Alabama and 84 other locations | Recruiting | Oct 13, 2023 |
| Identifying biomarkers for lung transplant dysfunction | — | Suresnes | Recruiting | Apr 8, 2021 |
| Evaluating new diagnostic methods for lung transplant rejection | — | Phoenix, Arizona and 10 other locations | Recruiting | Jun 24, 2016 |
All recruiting trials (7)
-
Hyperpolarized xenon-129 MRI signatures to detect and manage acute cellular rejection after lung transplant
We will see if hyperpolarized xenon-129 MRI can detect early acute cellular rejection in recent lung transplant recipients and guide targeted bronchoscopic sampling.
-
Comparing biopsy methods for lung transplant rejection diagnosis
This study tests which of two methods for taking lung tissue samples works better for diagnosing rejection in lung transplant patients.
-
Research on improving outcomes for lung transplant donors and recipients
This study is trying to see how different donor and medical practices affect the health of lung transplant patients and donors, while also looking for blood markers that might predict complications after the surgery.
-
Evaluating extracorporeal photopheresis for subclinical lung transplant rejection
This study is testing if a light-based treatment called extracorporeal photopheresis can help lung transplant patients who have early signs of rejection feel better and improve their health.
-
Testing the effectiveness of belumosudil for treating lung transplant rejection
This study is testing if belumosudil can help improve lung function in adults who have had a lung transplant and are experiencing ongoing issues with their new lungs.
-
Identifying biomarkers for lung transplant dysfunction
This study is trying to find specific markers in the body that can help doctors understand and manage problems after lung transplants for patients at Foch Hospital.
-
Evaluating new diagnostic methods for lung transplant rejection
This study is testing a new diagnostic tool to see if it can better identify lung transplant rejection in patients who are having problems with their transplanted lungs.
Related topics
Quick answers
How many Lung Transplant Rejection clinical trials are recruiting right now?
7, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 23 countries. The most sites are in United States (5 trials), France (3 trials), Austria (3 trials), Canada (3 trials), Australia (2 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.